JPMorgan CEO Dimon Indicates Shift Toward AI Hiring Fewer Traditional Bankers Kevin Warsh Takes Over as Fed Chair Pledges ReformOriented Agenda at White House Ceremony Wall Street Mixed Consumer Strength Battles Tech and Energy Weakness Apples Record Stock Rally Faces a Pivotal Test at WWDC 2026 AI Strategy in Focus Micron Reportedly Surpasses 1 Trillion Market Cap Amid Unprecedented Support from Trump and Wall Street Japan Hotel Rates Surge as Western Tourists Fill Gap Left by Fewer Chinese Visitors Biomea Fusion Inc BMEA Q1 2026 Earnings EPS Surprise of Nearly 30 Drives Positive Market Response TUSK Q1 2026 Earnings Profitability Achieved with EPS of 010 Stock Declines Slightly DJCO Q4 2025 Earnings Strong EPS Beat Amid Sparse Disclosure Hennessy Advisors Inc HNNA Q1 2026 Earnings Stable Earnings Amid Quiet Market Reaction Trinity Capital Inc TRIN Q1 2026 Earnings EPS Beats Estimates by 116 Camden National Corporation CAC Q1 2026 Earnings EPS Beat Surprises Amid Regional Banking Headwinds MDxHealth MDXH Slides 625 as Cancer Diagnostics Stock Tests Key Support Level Vaxcyte Inc PCVX Slips 14 as Shares Test Key Support Zone Hawthorn Bancshares HWBK Holds Steady at 3694 as Consolidation Continues Inflection Point Acquisition Corp V Units IPEXU Holds Steady at 1099 as SPAC Consolidates Karbon Capital Partners Warrants Surge Over 20 Support and Resistance Levels in Focus Gray Divorce at 60 Buying Out a Spouse Could Strain Retirement Finances Barings BDC Inc BBDC Q1 2026 Earnings EPS Misses Estimates Amid Stable Market Conditions BGM Group Ltd BGM Shows Modest Uptick as Stock Tests Key Resistance Level LOW Q1 2026 Earnings Earnings Beat Estimates as Consumer Caution Weighs on Shares Ames National Corporation ATLO Q1 2026 Earnings Solid EPS Beat Amid Stable Operations Atmus Filtration Technologies Q1 2026 Earnings EPS Beat Drives Positive Momentum LAMR Q1 2026 Earnings EPS Beat Highlights Strong Profitability WFG Q1 2026 Earnings EPS Beats Estimates Significantly Despite Loss IBRX Q1 2026 Earnings EPS Miss as Biotech Continues PreRevenue Advancement ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Continued Clinical Progress